
Please try another search
Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. It also manufactures aquatic, cosmetic, and biotechnology products, as well as traditional herbal medicines, food supplements, over-the-counter products, and herbal extracts; and offers management services. Y.S.P. Southeast Asia Holding Berhad was founded in 1987 and is headquartered in Kuala Lumpur, Malaysia.
Name | Age | Since | Title |
---|---|---|---|
Fang-Hsin Lee | 61 | 2003 | Group MD, President & Executive Director |
Ling-Chin Lee | 73 | 2005 | Non-Independent & Non-Executive Director |
Anis Bin Ahmad | 77 | 2002 | Non Independent & Non Executive Chairman |
Chew Mun Chin | 52 | 2018 | Independent & Non-Executive Director |
Teck Kong Yau | 61 | 2022 | Independent Non Executive Director |
Hasnah Binti Ismail | 71 | 2018 | Independent & Non-Executive Director |
Salmah Binti Bahri | 64 | 2021 | Independent & Non-Executive Director |
Sen Huei Lee | 39 | 2023 | Non-Independent Non Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review